This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Dr. Hirotsugu Tanaka, PhD
Crafton Biotechnology における Chief Scientific Officer
スピーカー

プロフィール

Hirotsugu Tanaka, Ph.D., is the Chief Scientific Officer at Crafton Biotechnology, where he leads drug discovery and pipeline development. He has worked at Astellas Pharma Inc. for over 20 years. Originally trained as a molecular biologist and pharmacologist, he has led global R&D projects and corporate strategic initiatives as a global leader. Since 2018, he has headed an mRNA therapy research team in Boston and overseen mRNA research laboratories, fostering multiple collaborations across academia and industry in the U.S. and Japan.

アジェンダセッション

  • Building a Clinically Ready mRNA Oncology Platform: Expression, Purity, Intradermal Delivery, and Translational Insights from a Government-Supported COVID Trial

    9:15am